USPTO serial 79293448
IMATRIX
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- May 31, 2022
- Examiner
- SMITH, CYNTHIA RINALDI
- Law office
- PUBLICATION AND ISSUE SECTION
What this means
Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six. Calendar Section 8 between years five and six, and consider trademark monitoring.
Need help with IMATRIX?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Proteins for use in the manufacture of pharmaceuticals and biological preparations other than for medical or veterinary use; Proteins in raw material form for scientific and medical research use to enhance cell proliferation and viability, other than for medical or veterinary use; proteins in raw material form for scientific and medical research use as substrates in cell cultures, other than for medical or veterinary use; biological reagents for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical preparations for scientific and medical research use in cell cultures other than for medical or veterinary use; chemical reagents for use in cell cultures other than for medical or veterinary use; proteins in raw material form for scientific and medical research, other than for medical or veterinary use; chemical preparations for scientific and medical research use other than for medical or veterinary use; chemical reagents other than for medical or veterinary use | ACTIVE | — |
| 005 | Cell culture substrates, namely, protein specifically adapted for use with nucleic acid sequences for use in cell cultures for medical, clinical, and veterinary diagnostic use; reagents for use in cell cultures for medical, clinical medical, and veterinary diagnostic use; proteins specially adapted for use with nucleic acid sequences for medical purposes; chemical reagents for medical and veterinary use; chemical preparations for medical purposes, namely, reagents for medical use | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Nippi, Incorporated
- Other trademarks owned by Nippi, Incorporated
- Other trademarks owned by Nippi, Incorporated
- Other trademarks in Class 001
- Other trademarks in Class 005
- Similar marks named IMATRIX
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 3, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 11, 2026 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Oct 10, 2022 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Sep 15, 2022 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Sep 15, 2022 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Aug 31, 2022 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| May 31, 2022 | NRCC | NOTICE OF REGISTRATION CONFIRMATION EMAILED | — |
| May 31, 2022 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 24, 2022 | ETOP | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED | — |
| Mar 7, 2022 | OPNX | NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB | — |
| Feb 16, 2022 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Feb 16, 2022 | OPNR | NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB | — |
| Jan 11, 2022 | ETOF | EXTENSION OF TIME TO OPPOSE RECEIVED | — |
| Dec 19, 2021 | GPNX | NOTIFICATION PROCESSED BY IB | — |
| Dec 14, 2021 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Dec 14, 2021 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Nov 24, 2021 | OPNS | NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB | — |
| Nov 24, 2021 | OP2R | NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB | — |
| Nov 24, 2021 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Nov 11, 2021 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Nov 11, 2021 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Nov 11, 2021 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2021 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Nov 11, 2021 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Oct 18, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Oct 17, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Oct 17, 2021 | ERFR | TEAS REQUEST FOR RECONSIDERATION RECEIVED | — |
| Apr 19, 2021 | GNFN | NOTIFICATION OF FINAL REFUSAL EMAILED | — |
| Apr 19, 2021 | GNFR | FINAL REFUSAL E-MAILED | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Apr 19, 2021 | CNFR | FINAL REFUSAL WRITTEN | A final Office Action (final refusal) means the examining attorney is maintaining at least one refusal and your options are narrower. You can file a response addressing the refusal, appeal to the Trademark Trial and Appeal Board, or let the application abandon. |
| Mar 29, 2021 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 29, 2021 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 29, 2021 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Nov 2, 2020 | RFNT | REFUSAL PROCESSED BY IB | — |
| Oct 10, 2020 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Oct 10, 2020 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Sep 22, 2020 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Sep 19, 2020 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Sep 18, 2020 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 16, 2020 | DOCK | ASSIGNED TO EXAMINER | — |
| Sep 16, 2020 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Sep 15, 2020 | LIMI | LIMITATION FROM ORIGINAL APPLICATION ENTERED | — |
| Sep 10, 2020 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |